| P50 | author | Kevin A Hildebrand | Q38320472 |
| P2093 | author name string | David A Hart | |
| | A Dean Befus | |
| | Michael J Monument | |
| | Paul T Salo | |
| P2860 | cites work | The mast cell stabilizer ketotifen prevents development of excessive skin wound contraction and fibrosis in red Duroc pigs | Q46719515 |
| | Involvement of mast cells in the development of fibrosis in rats with postmyocarditis dilated cardiomyopathy | Q46792783 |
| | Neuropeptides activate human mast cell degranulation and chemokine production | Q46961068 |
| | Rabbit knee model of post-traumatic joint contractures: the long-term natural history of motion loss and myofibroblasts | Q47972377 |
| | Increased types I and III collagen and transforming growth factor-beta 1 mRNA and protein in hypertrophic burn scar | Q49168259 |
| | Mast cells are a source of transforming growth factor β in systemic sclerosis | Q50282434 |
| | Scarless healing of oral mucosa is characterized by faster resolution of inflammation and control of myofibroblast action compared to skin wounds in the red Duroc pig model. | Q50594532 |
| | Transforming growth factor-beta in thermally injured patients with hypertrophic scars: effects of interferon alpha-2b. | Q50862391 |
| | Fibrocytes from burn patients regulate the activities of fibroblasts. | Q51081479 |
| | Substance P immunoreactive fibers of synovial tissue in patients with anterior cruciate ligament injury. | Q51825535 |
| | Myofibroblast cells are preferentially expressed early in a rabbit model of joint contracture. | Q53207783 |
| | Analysis of neuropeptides in stretched skin. | Q54475247 |
| | Mast cells are required for normal healing of skin wounds in mice | Q80243613 |
| | The neuropeptide substance P is a critical mediator of burn-induced acute lung injury | Q81394926 |
| | Keloid and hypertrophic scarring may result from a mechanoreceptor or mechanosensitive nociceptor disorder | Q81611135 |
| | Double-edged effects of neuropeptide substance P on repair of cutaneous trauma | Q84095015 |
| | Mechanobiology of scarring | Q84599687 |
| | Ketotifen alone or as additional medication for long-term control of asthma and wheeze in children | Q24247455 |
| | Biology of fibroblasts and myofibroblasts | Q24650762 |
| | Dupuytren's contracture is associated with sprouting of substance P positive nerve fibres and infiltration by mast cells | Q24675437 |
| | Myofibroblasts and mechano-regulation of connective tissue remodelling | Q28216468 |
| | Prevention of mast-cell degranulation by ketotifen in patients with physical urticarias | Q28336727 |
| | Changes in matrix metalloproteinases during the evolution of interstitial renal fibrosis in a rat experimental model | Q28578669 |
| | Regulation of wound healing by growth factors and cytokines | Q29615242 |
| | Specificity and versatility in tgf-beta signaling through Smads | Q29616324 |
| | Factors affecting the outcome of trabeculectomy: an analysis based on combined data from two phase III studies of an antibody to transforming growth factor beta2, CAT-152. | Q31122597 |
| | The roles of Transforming growth Factor Type ?3(TGF-?3) and mast cells in the pathogenesis of scleroderma | Q33193227 |
| | Myofibroblasts. I. Paracrine cells important in health and disease | Q33688939 |
| | Mechanisms of myofibroblast activity and phenotypic modulation. | Q33691240 |
| | Fibrosis and cancer: do myofibroblasts come also from epithelial cells via EMT? | Q33727178 |
| | The effects of topical sodium cromoglicate on itch and flare in human skin induced by intradermal histamine: a randomised double-blind vehicle controlled intra-subject design trial | Q33840088 |
| | Histology of the thick scar on the female, red Duroc pig: final similarities to human hypertrophic scar | Q33884267 |
| | TGF-beta1 and radiation fibrosis: a master switch and a specific therapeutic target? | Q33913350 |
| | Mediators leading to fibrosis - how to measure and control them in tissue engineering. | Q34159587 |
| | Myofibroblast numbers are elevated in human elbow capsules after trauma | Q34176422 |
| | Joint capsule matrix turnover in a rabbit model of chronic joint contractures: Correlation with human contractures | Q34176428 |
| | High rate of joint capsule matrix turnover in chronic human elbow contractures | Q34176433 |
| | Joint capsule mast cells and neuropeptides are increased within four weeks of injury and remain elevated in chronic stages of posttraumatic contractures | Q34179814 |
| | Myofibroblast upregulators are elevated in joint capsules in posttraumatic contractures. | Q34267587 |
| | Regional variation is present in elbow capsules after injury | Q34267593 |
| | Degranulation of human mast cells induces an endothelial antigen central to leukocyte adhesion | Q34320131 |
| | Mast cells promote fibroblast populated collagen lattice contraction through gap junction intercellular communication | Q34329952 |
| | The proto-oncogene c-kit encoding a transmembrane tyrosine kinase receptor maps to the mouse W locus | Q34407347 |
| | The human mast cell: an overview | Q34444240 |
| | The mast cell stabilizer ketotifen fumarate lessens contracture severity and myofibroblast hyperplasia: a study of a rabbit model of posttraumatic joint contractures | Q34550614 |
| | Apoptosis and myofibroblasts in the pathogenesis of systemic sclerosis | Q34560715 |
| | Ketotifen: Current Views on Its Mechanism of Action and Their Therapeutic Implications | Q34707792 |
| | Biological role and clinical implications of mast cells in surgery | Q34732159 |
| | Mast cells in the pathogenesis of fibrosis | Q35082007 |
| | Determination of plasma Ntau-methylhistamine in vivo by isotope dilution using benchtop gas chromatography-mass spectrometry | Q42548491 |
| | The deletion of transforming growth factor-beta-induced myofibroblasts depends on growth conditions and actin organization | Q42795127 |
| | Recombinant human stem cell factor stimulates differentiation of mast cells from dispersed human fetal liver cells | Q42814084 |
| | Apposition of fibroblasts to mast cells and lymphocytes in normal human lung and in cryptogenic fibrosing alveolitis. Ultrastructure and cell perimeter measurements | Q43441031 |
| | Co-cultured human mast cells stimulate fibroblast-mediated contraction of collagen gels | Q43568785 |
| | Fibroblasts from idiopathic pulmonary fibrosis and normal lungs differ in growth rate, apoptosis, and tissue inhibitor of metalloproteinases expression | Q43606201 |
| | Role of mast cell tryptase in renal interstitial fibrosis | Q43680956 |
| | The role of mast cell degranulation products in mast cell hyperplasia. I. Mechanism of action of nerve growth factor | Q43684050 |
| | Comparison of the modulatory effect of ketotifen, sodium cromoglycate, procaterol and salbutamol in human skin, lung and tonsil mast cells | Q43720282 |
| | A novel TGF-beta antagonist speeds reepithelialization and reduces scarring of partial thickness porcine burns. | Q43960747 |
| | Kinetics of macrophages, myofibroblasts and mast cells in carbon tetrachloride-induced rat liver cirrhosis | Q43996237 |
| | The role of sodium cromolyn in treatment of paraquat-induced pulmonary fibrosis in rat. | Q44131266 |
| | Collagen polymorphism in pathologic human scars | Q44197898 |
| | Alpha-smooth muscle actin is transiently expressed by myofibroblasts during experimental wound healing. | Q44245074 |
| | Evolution of substance P immunofluorescent nerves in callus tissue during fracture healing | Q44279075 |
| | Induction of human cutaneous mast cell degranulation by opiates and endogenous opioid peptides: Evidence for opiate and nonopiate receptor participation | Q44330272 |
| | Enhanced Skin Permeation of Cationic Drug Ketotifen through Excised Guinea Pig Dorsal Skin by Surfactants with Different Electric Charges | Q44603053 |
| | Substance P and arthritis: analysis of plasma and synovial fluid levels. | Q44911778 |
| | Mast cell changes in scleroderma. Presence of MCT cells in the skin and evidence of mast cell activation | Q44916752 |
| | A double-blind randomized controlled trial of ketotifen versus placebo in early diffuse scleroderma | Q45204915 |
| | Substance P levels and neutral endopeptidase activity in acute burn wounds and hypertrophic scar | Q46406677 |
| | Host-mediated effectors of tumor invasion: role of mast cells in matrix degradation | Q46411361 |
| | Involvement of calcium ions in the mode of action of disodium cromoglycate and ketotifen on smooth muscle | Q46580623 |
| | The myofibroblast in wound healing and fibrocontractive diseases | Q35170446 |
| | Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases | Q35649473 |
| | Wound healing: an overview of acute, fibrotic and delayed healing | Q35650806 |
| | Mast cells contribute to scar formation during fetal wound healing | Q35672929 |
| | The ins and outs of IgE-dependent mast-cell exocytosis | Q35751914 |
| | Enhanced expression of transforming growth factor-beta type I and type II receptors in wound granulation tissue and hypertrophic scar | Q35763720 |
| | TGF-beta1 and angiotensin networking in cardiac remodeling | Q35846911 |
| | Cromolyn sodium: fitting an old friend into current asthma treatment | Q36116260 |
| | Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts | Q36232642 |
| | Effect of antibody to transforming growth factor beta on bleomycin induced accumulation of lung collagen in mice | Q36287478 |
| | Diagnostic value of tryptase in anaphylaxis and mastocytosis | Q36576420 |
| | Basophil and mast cell lineages in vitro and in vivo | Q36763910 |
| | Differential release of mast cell mediators and the pathogenesis of inflammation | Q36819882 |
| | The mast cell: where endocytosis and regulated exocytosis meet | Q36819946 |
| | The mast cell stabilizer ketotifen reduces joint capsule fibrosis in a rabbit model of post-traumatic joint contractures | Q37008430 |
| | A new method to measure post-traumatic joint contractures in the rabbit knee | Q37017828 |
| | Comparative electron microscopy of basophils and mast cells, in vivo and in vitro | Q37424850 |
| | 3T3 fibroblasts induce cloned interleukin 3-dependent mouse mast cells to resemble connective tissue mast cells in granular constituency | Q37483681 |
| | Neuronal pathways in tendon healing | Q37501823 |
| | Diverse roles of TGF-β/Smads in renal fibrosis and inflammation | Q37934555 |
| | Leukocyte adhesion to endothelium in inflammation | Q37938615 |
| | Ketotifen. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in asthma and allergic disorders | Q37977366 |
| | Wound repair and regeneration | Q38026474 |
| | Posttraumatic elbow contractures: targeting neuroinflammatory fibrogenic mechanisms. | Q38134274 |
| | Substance P and calcitonin gene-related peptide: effects on mast cells and in human skin. | Q38173971 |
| | Human mast cell proteases and mast cell heterogeneity | Q38706970 |
| | Histamine and its metabolism in mammals. Part II: Catabolism of histamine and histamine liberation | Q39495885 |
| | Rat mast cells communicate with fibroblasts via gap junction intercellular communications | Q40216067 |
| | Mast cells: accessory cells which potentiate fibrosis | Q40403511 |
| | The differentiation and function of myofibroblasts is regulated by mast cell mediators | Q40768319 |
| | Mast cells enhance contraction of three-dimensional collagen lattices by fibroblasts by cell-cell interaction: role of stem cell factor/c-kit. | Q40894574 |
| | Pharmacology of sodium cromoglycate | Q41113700 |
| | Mast cells at sites of cartilage erosion in the rheumatoid joint | Q41137008 |
| | Immunofluorescent staining for mast cells in idiopathic pulmonary fibrosis: quantification and evidence for extracellular release of mast cell tryptase | Q41599986 |
| | Human lung mast cells and pulmonary macrophages produce tumor necrosis factor-alpha in sensitized lung tissue after IgE receptor triggering | Q41601330 |
| | Ultrastructure of pulmonary mast cells in patients with fibrotic lung disorders | Q41640529 |
| | Transforming growth factor-beta production by dog mastocytoma cells. Storage and release from mast cell granules | Q41692789 |
| | The kit ligand: A cell surface molecule altered in steel mutant fibroblasts | Q41718670 |
| | Overexpression of Bcl-2 by activated human hepatic stellate cells: resistance to apoptosis as a mechanism of progressive hepatic fibrogenesis in humans. | Q42063388 |
| | Formulation and optimization of nano-sized ethosomes for enhanced transdermal delivery of cromolyn sodium | Q42413141 |
| | The temporal effects of anti-TGF-beta1, 2, and 3 monoclonal antibody on wound healing and hypertrophic scar formation. | Q54646739 |
| | The collagen changes of Dupuytren's contracture. | Q55052053 |
| | Ketotifen effect on secretion of histamine from basophils and on proliferative response of mononuclear cells of human peripheral blood | Q57775380 |
| | Impaired mast cell-dependent natural immunity in complement C3-deficient mice | Q59049556 |
| | Recombinant human anti–transforming growth factor β1 antibody therapy in systemic sclerosis: A multicenter, randomized, placebo-controlled phase I/II trial of CAT-192 | Q61646585 |
| | Inhibition profiles of sodium cromoglycate and nedocromil sodium on mediator release from mast cells of human skin, lung, tonsil, adenoid and intestine | Q67535901 |
| | Degranulation of basophilic leukocytes in allergic contact dermatitis reactions in man | Q67758073 |
| | Necessity of extracellular domain of W (c-kit) receptors for attachment of murine cultured mast cells to fibroblasts | Q67894935 |
| | Ketotifen prevents skin fibrosis in the tight skin mouse | Q68728759 |
| | Ketotifen-induced remission in progressive early diffuse scleroderma: evidence for the role of mast cells in disease pathogenesis | Q68901136 |
| | Mechanical analysis of hypertrophic scar tissue: structural basis for apparent increased rigidity | Q70044910 |
| | Ketotifen increases cyclic adenosine 3',5'-monophosphate in intact human lymphocyte and potentiates other adenylate cyclase activating agents | Q70171668 |
| | Susceptibility of soluble and matrix fibronectins to degradation by tissue proteinases, mast cell chymase and cathepsin G | Q70537730 |
| | Fracture healing and mast cells | Q70979418 |
| | Neutralization of TGF-beta by anti-TGF-beta antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice | Q71006993 |
| | An overview of ketotifen | Q71605773 |
| | Substance P-like immunoreactive substance in bronchoalveolar lavage fluids from patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis | Q71671620 |
| | [Substance P and vasoactive intestinal peptide in patients with progressive scleroderma. Determination of plasma level before and after autogenic training] | Q71686556 |
| | Increased expression of transforming growth factor beta isoforms (beta 1, beta 2, beta 3) in bleomycin-induced pulmonary fibrosis | Q71699580 |
| | Neutralisation of TGF-beta 1 and TGF-beta 2 or exogenous addition of TGF-beta 3 to cutaneous rat wounds reduces scarring | Q71702949 |
| | Transforming growth factor-beta production during the development of renal fibrosis in rats with subtotal renal ablation | Q71834586 |
| | Angiotensin I Conversion by Human and Rat Chymotryptic Proteinases | Q72398088 |
| | The Pharmacology of Ketotifen | Q72527592 |
| | Substance P | Q72718977 |
| | Increased levels of type I and III collagen and hyaluronan in scleroderma skin | Q73086977 |
| | Role of apoptosis and transforming growth factor beta1 in fibroblast selection and activation in systemic sclerosis | Q73092717 |
| | Inhibition of myofibroblast apoptosis by transforming growth factor beta(1) | Q73205575 |
| | Mast cell tryptase stimulates human lung fibroblast proliferation via protease-activated receptor-2 | Q73382005 |
| | Transforming growth factor-beta mRNA and protein in hypertrophic scar tissues and fibroblasts: antagonism by IFN-alpha and IFN-gamma in vitro and in vivo | Q73542541 |
| | The association between frozen shoulder and Dupuytren's disease | Q73766114 |
| | Transforming growth factor-beta1 promotes the morphological and functional differentiation of the myofibroblast | Q73896690 |
| | Peripheral blood fibrocytes: differentiation pathway and migration to wound sites | Q73966720 |
| | The association of serum matrix metalloproteinases and their tissue inhibitor levels with scleroderma disease severity | Q74249547 |
| | Transforming growth factor-beta function blocking prevents myocardial fibrosis and diastolic dysfunction in pressure-overloaded rats | Q74397793 |
| | Myofibroblasts and apoptosis in human hypertrophic scars: the effect of interferon-alpha2b | Q77090602 |
| | The cutaneous microfibrillar apparatus contains latent transforming growth factor-beta binding protein-1 (LTBP-1) and is a repository for latent TGF-beta1 | Q77386419 |
| | Neuropeptides: mediators of inflammation and tissue repair? | Q77469791 |
| | Mast cell subpopulations in the synovial tissue of patients with osteoarthritis: selective increase in numbers of tryptase-positive, chymase-negative mast cells | Q77753232 |
| | The potential role of transforming growth factor beta in fracture healing | Q77902289 |
| | Mast cells in rapidly progressive glomerulonephritis | Q77998416 |
| | Anti-sclerotic effect of transforming growth factor-beta antibody in a mouse model of bleomycin-induced scleroderma | Q78021748 |
| | Expression of basic fibroblast growth factor and its receptor by fibroblast, macrophages and mast cells in hypertrophic scar | Q78031938 |
| | Expression of transforming growth factor beta 1, 2, and 3 proteins in keloids | Q78148901 |
| | Bone marrow-derived myofibroblasts recruited to the upper dermis appear beneath regenerating epidermis after deep dermal burn injury | Q79629920 |
| | A complete expression profile of matrix-degrading metalloproteinases in Dupuytren's disease | Q79870821 |
| P433 | issue | 3 | |
| P921 | main subject | mast cell | Q191989 |
| | connective tissue | Q25615 |
| P304 | page(s) | 137-151 | |
| P577 | publication date | 2015-03-01 | |
| P1433 | published in | Advances in Wound Care | Q26842854 |
| P1476 | title | Neuroinflammatory Mechanisms of Connective Tissue Fibrosis: Targeting Neurogenic and Mast Cell Contributions | |
| P478 | volume | 4 | |